Technical Analysis for PKBO - Peak Bio Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | -5.71% | |
Hot IPO Pullback | Bullish Swing Setup | -5.71% | |
Narrow Range Bar | Range Contraction | -5.71% | |
Inside Day | Range Contraction | -5.71% | |
Gapped Up | Strength | -5.71% | |
Hammer Candlestick | Bullish | -4.35% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Gapped Up (Partial) | 20 days ago |
Up 3% | 20 days ago |
Up 2% | 20 days ago |
Up 1% | 20 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. Its lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate for solid tumors. The company was founded in 2020 and is headquartered in Palo Alto, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Pharmaceutical Industry Life Sciences Biopharmaceutical Pharmacy Solid Tumors Alpha Inflammatory Acute Respiratory Distress Syndrome Antitrypsin Deficiency
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Pharmaceutical Industry Life Sciences Biopharmaceutical Pharmacy Solid Tumors Alpha Inflammatory Acute Respiratory Distress Syndrome Antitrypsin Deficiency
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 1.75 |
52 Week Low | 1.05 |
Average Volume | 6,227 |
200-Day Moving Average | 0.0000 |
50-Day Moving Average | 0.0000 |
20-Day Moving Average | 0.0000 |
10-Day Moving Average | 1.4863 |
Average True Range | 0.1502 |
RSI | 42.20 |
ADX | 0.0 |
+DI | 15.1750 |
-DI | 47.5414 |
Chandelier Exit (Long, 3 ATRs) | 1.2994 |
Chandelier Exit (Short, 3 ATRs) | 1.5006 |
Upper Bollinger Bands | 0.0000 |
Lower Bollinger Band | 0.0000 |
Percent B (%b) | 0.0 |
BandWidth | 0.0000 |
MACD Line | -0.0581 |
MACD Signal Line | -0.0269 |
MACD Histogram | -0.0312 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.3200 | ||||
Resistance 3 (R3) | 1.3200 | 1.3200 | 1.3200 | ||
Resistance 2 (R2) | 1.3200 | 1.3200 | 1.3200 | 1.3200 | |
Resistance 1 (R1) | 1.3200 | 1.3200 | 1.3200 | 1.3200 | 1.3200 |
Pivot Point | 1.3200 | 1.3200 | 1.3200 | 1.3200 | 1.3200 |
Support 1 (S1) | 1.3200 | 1.3200 | 1.3200 | 1.3200 | 1.3200 |
Support 2 (S2) | 1.3200 | 1.3200 | 1.3200 | 1.3200 | |
Support 3 (S3) | 1.3200 | 1.3200 | 1.3200 | ||
Support 4 (S4) | 1.3200 |